AWVKVVEEKAFSPEVIPMF

Product Name

AWVKVVEEKAFSPEVIPMF

Product Quantity
4mg, >95%
Catalog Number
LT8218
Formula
C106H160N22O27S
Molecular Weight
2206.63
Sequence

AWVKVVEEKAFSPEVIPMF

Product Description


Frequencies of Subtype-Specific Amino Acid Combinations in HIV-B- and HIV-C-Infected Individuals and an Outline of the Overlapping 25-mer Peptides Used as Proteasomal Substrates. For example, CF1 fragment, subtype B, Subtype-Specific Motif 27V, 41T, AWVKVVEEKAFSPEVIPMF, was used for the study.

Antigen processing is one crucial step in the pathway responsible for HLA presentation of HIV epitopes to CTL. It is a multistep process, where viral proteins synthesized in infected cells are first degraded by cytosolic proteasomes. A multilevel linear model was used to examine the influence of the presenting HLA allelic frequencies, HIV region (NF1, CF1, MF2&CF2), and ethnic group (Africans, whites) on epitope yield.

A strong relationship between epitope yield and HLA allelic frequency was found for NF1, CF1 and MF2&CF2, but, whereas similar variation in HLA frequency had similar effects on epitope yields in NF1 and MF2&CF2 regardless of ethnic group, a significant difference between ethnic groups was found with respect to CF1 (p < 0.0001).

Vulnerable regions within other HIV proteins may also demonstrate variable adaptation to the same HLA selective pressure, in line with the different HIV B and HIV C CF1 epitope yields.


  • 10 Units in Stock

Ask a Question

$250.00

Add to Cart:
LifeTein LifeTein provides custom peptide synthesis service, recombinant proteins, peptides, cytokines, custom antibody service and custom protein service. LifeTein is the world leader in fast peptide synthesis service with lab facility located in New Jersey USA. LifeTein Logo 100 Randolph Road, Suite 2D, Somerset USA New Jersey 08873
Copyright © 2024 LifeTein.com. Powered by LifeTein